INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2007

Intragastric balloon increases temporary satiety without altering plasma ghrelin in morbid obesity.

In a 4-month randomized sham-controlled trial of 21 patients with morbid obesity, weight decreased significantly in both balloon (143.8 to 131.1 kg) and sham groups (138.8 to 129.9 kg), with no significant difference between groups. The intragastric balloon caused a temporary rise in pre- and postprandial satiety peaking at 4 weeks. However, fasting, postprandial, and area under the curve ghrelin levels did not differ between groups and did not correlate with satiety scores.

Study type
Randomized controlled trial
Who was studied
21 adults with treatment-resistant morbid obesity (mean BMI 50.4 kg/m2)
What was measured
Satiety, plasma ghrelin levels, and body weight

THE PAPER

Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity.

Martinez-Brocca MA, Belda O, Parejo J, Jimenez L, del Valle A, Pereira JL, Garcia-Pesquera F, Astorga R, Leal-Cerro A, Garcia-Luna PP. Obes Surg, 2007.

PubMed 17658025 ↗DOI 10.1007/s11695-007-9109-z ↗

Weight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.